A single-blinded randomised controlled study to determine the efficacy of Omnilux Revive facial treatment in skin rejuvenation

Lasers Med Sci. 2005;20(1):6-10. doi: 10.1007/s10103-005-0330-5. Epub 2005 May 21.


To determine the efficacy of Omnilux Revive facial treatment in skin rejuvenation, twenty-three volunteers received randomised 20 min treatments three times a week for three weeks to one half of their face, with the untreated side acting as control. Regular assessments were carried out, focusing on parameters of subject satisfaction, photographic assessments, skin elasticity (Cutometer) and skin hydration (Corneometer CM825). Ninety-one percent of the volunteers reported visible changes to their skin. Blinded photographic evaluation reported a clinical response in 59% of the subjects. Objective analysis failed to show statistically significant changes in skin hydration or elasticity. The Omnilux Revive LED lamp is a safe alternative non-ablative skin rejuvenation treatment.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Dermabrasion / methods
  • Dermatologic Agents / therapeutic use*
  • Elasticity
  • Esthetics
  • Face
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patient Satisfaction
  • Phototherapy / methods*
  • Reference Values
  • Rejuvenation
  • Risk Assessment
  • Single-Blind Method
  • Skin Aging / drug effects*
  • Treatment Outcome


  • Dermatologic Agents